From Bioprocess Design to Bioactivity: a new platform for antimicrobial-producing lactic acid bacteria
Biotechnology Reports · 2026-12 · 52 · e00988
DOI: 10.1016/j.btre.2026.e00988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Reports, 2026-12. Verfasst von Alberto Alfano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero dell'Istruzione dell'Università e della Ricerca.
Abstract (Originalsprache)
Lactic acid bacteria (LAB) produce antimicrobial compounds with potential applications as natural food preservatives and alternatives to conventional antibiotics. However, their industrial use is limited by the high cost of conventional culture media and inefficient downstream recovery. This study developed an integrated, scalable, and cost-effective bioprocess for producing and recovering antibacterial metabolites from four LAB strains: Lactiplantibacillus plantarum, Limosilactobacillus reuteri, Lacticaseibacillus paracasei, and Lacticaseibacillus rhamnosus. Culture medium optimization, fermentation intensification, and membrane-based downstream processing were investigated. Fed-batch cultivation achieved approximately three-fold higher biomass and secreted protein production than batch fermentation. Cell-free broths were processed by sequential ultrafiltration/diafiltration using 10 and 2 kDa membranes to obtain bacteriocin-enriched fractions. These fractions exhibited strong antimicrobial activity against selected skin and intestinal pathogens, reducing viable counts by up to 7-8 Log₁₀ CFU/mL. The proposed bioprocess provides a promising basis for the future scale-up of LAB-derived antibacterial peptides production for food and health applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Department of Environmental Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", Caserta, Italy.
- Department of Life Sciences, Health and Healthcare Professions, Link Campus University, Rome, Italy.
- Department of Women, Children, General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
Förderung
- Ministero dell'Istruzione dell'Università e della Ricerca
Zitieren
APA
Alfano, A., Negash, A. W., Izzo, S., Chiaromonte, A., Bianchi, M., Amato, B., Cimini, D., Fusco, A., Esin, S., Batoni, G., Donnarumma, G., & Schiraldi, C. (2026). From Bioprocess Design to Bioactivity: a new platform for antimicrobial-producing lactic acid bacteria. Biotechnology Reports, 52, e00988. https://doi.org/10.1016/j.btre.2026.e00988
Vancouver
Alfano A, Negash AW, Izzo S, Chiaromonte A, Bianchi M, Amato B, et al. From Bioprocess Design to Bioactivity: a new platform for antimicrobial-producing lactic acid bacteria. Biotechnology Reports. 2026;52:e00988. doi:10.1016/j.btre.2026.e00988
BibTeX
@article{Alfano2026,
author = {Alfano, Alberto and Negash, Abebe Worku and Izzo, Simona and Chiaromonte, Adriana and Bianchi, Marta and Amato, Beatrice and Cimini, Donatella and Fusco, Alessandra and Esin, Semih and Batoni, Giovanna and Donnarumma, Giovanna and Schiraldi, Chiara},
title = {From Bioprocess Design to Bioactivity: a new platform for antimicrobial-producing lactic acid bacteria},
journal = {Biotechnology Reports},
year = {2026},
volume = {52},
pages = {e00988},
doi = {10.1016/j.btre.2026.e00988}
}
EUVIMED